Protara Therapeutics, Inc. — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-07-07

Reporting Person: Gottlieb Daniel Philip (VP Marketing & Bus Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-30	Common Stock	A	1965	$8.84	Acquired	1965	Direct
2015-07-07	Common Stock	S	1965	$16.86	Disposed	0	Direct

Footnotes

F1: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: These shares, acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), were sold under Rule 144 and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2015.